This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Email citation

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

. 2004 Oct;22(10):1198.

doi: 10.1038/nbt1004-1198.

Genentech discloses safety concerns over Avastin

PMID: 15470443
DOI: 10.1038/nbt1004-1198

Genentech discloses safety concerns over Avastin

Mark Ratner. Nat Biotechnol. 2004 Oct.

. 2004 Oct;22(10):1198.

doi: 10.1038/nbt1004-1198.

Author

PMID: 15470443
DOI: 10.1038/nbt1004-1198

No abstract available

PubMed Disclaimer

Similar articles

The role of the data safety monitoring board: why was the Avastin phase III clinical trial stopped?
McLemore MR. McLemore MR. Clin J Oncol Nurs. 2006 Apr;10(2):153-4. doi: 10.1188/06.CJON.153-154. Clin J Oncol Nurs. 2006. PMID: 16708697
FDA. Once on 'fast track,' avastin now derailed.
Couzin-Frankel J, Ogale Y. Couzin-Frankel J, et al. Science. 2011 Jul 8;333(6039):143-4. doi: 10.1126/science.333.6039.143. Science. 2011. PMID: 21737712 No abstract available.
Avastin hearing leads to more uncertainty over drug's future.
Goozner M. Goozner M. J Natl Cancer Inst. 2011 Aug 3;103(15):1148-50. doi: 10.1093/jnci/djr293. Epub 2011 Jul 18. J Natl Cancer Inst. 2011. PMID: 21768534 No abstract available.
Position paper: the need for head-to-head studies comparing Avastin versus Lucentis.
Schmucker C, Antes G, Lelgemann M. Schmucker C, et al. Surv Ophthalmol. 2009 Nov-Dec;54(6):705-7. doi: 10.1016/j.survophthal.2009.08.002. Surv Ophthalmol. 2009. PMID: 19818262 Review. No abstract available.
Monoclonal antibodies: production, uses and side effects.
Cowden J, Parker SK. Cowden J, et al. Pediatr Infect Dis J. 2006 Jun;25(6):553-5. doi: 10.1097/01.inf.0000223443.80696.5b. Pediatr Infect Dis J. 2006. PMID: 16732156 Review. No abstract available.

See all similar articles

Cited by

On the relationship of LDL and VEGFR1: not just a family affair.
Ylä-Herttuala S, Alitalo K. Ylä-Herttuala S, et al. EMBO Rep. 2007 Dec;8(12):1127-8. doi: 10.1038/sj.embor.7401124. EMBO Rep. 2007. PMID: 18059310 Free PMC article. No abstract available.
Tumor-specific interendothelial adhesion mediated by FLRT2 facilitates cancer aggressiveness.
Ando T, Tai-Nagara I, Sugiura Y, Kusumoto D, Okabayashi K, Kido Y, Sato K, Saya H, Navankasattusas S, Li DY, Suematsu M, Kitagawa Y, Seiradake E, Yamagishi S, Kubota Y. Ando T, et al. J Clin Invest. 2022 Mar 15;132(6):e153626. doi: 10.1172/JCI153626. J Clin Invest. 2022. PMID: 35104247 Free PMC article.
New approaches in angiogenic targeting for colorectal cancer.
Prat A, Casado E, Cortés J. Prat A, et al. World J Gastroenterol. 2007 Nov 28;13(44):5857-66. doi: 10.3748/wjg.v13.i44.5857. World J Gastroenterol. 2007. PMID: 17990351 Free PMC article. Review.
Bispecific Antibodies as a Development Platform for New Concepts and Treatment Strategies.
Yang F, Wen W, Qin W. Yang F, et al. Int J Mol Sci. 2016 Dec 28;18(1):48. doi: 10.3390/ijms18010048. Int J Mol Sci. 2016. PMID: 28036020 Free PMC article. Review.
A clinical cardiology perspective of thrombophilias.
Becker RC. Becker RC. J Thromb Thrombolysis. 2010 Oct;30(3):378-89. doi: 10.1007/s11239-010-0511-3. J Thromb Thrombolysis. 2010. PMID: 20711634

See all "Cited by" articles

Publication types

Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions
Actions
Actions

LinkOut - more resources

Full Text Sources
- Nature Publishing Group
Other Literature Sources
- The Lens - Patent Citations Database
Medical
- MedlinePlus Health Information